Fujiyama Power Systems shares debuted weakly on November 20, listing at ₹220 on NSE, 3.51% below its issue price. The IPO raised ₹828 crore, with strong QIB interest but overall underperformance ...

BAE Systems (LSE:BA.) shares have been in the spotlight following recent trading activity. Investors are weighing the company’s performance over the past month and considering what the latest movement ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

It’s the latest drugmaker to cut prices on popular GLP-1 weight loss drugs. Photos: AP Economist Pulls Apart Trump’s Latest Boasts: ‘My Kids Don’t Even Lie That Often’ Trump commutes 7-year prison ...

Wondering if Merit Medical Systems is trading at a bargain or if that ship has sailed? You are not alone; it is a common question for investors sizing up this healthcare stock. The stock has seen a ...

👋 Welcome to 5 Things PM! Throw another shrimp on the barbie. President Donald Trump said he’s looking Down Under for inspiration on how to improve the retirement savings system in the US. The ...

One of the major differences between the 2006 original release of The Elder Scrolls IV: Oblivion, and the 2025 Oblivion Remaster, is a larger overhaul to the game's leveling system. This page breaks ...

Over the last 5 years, the share price of Fujiyama Power Systems has declined 0.37% CAGR. Over the past year, the corresponding return has been -1.82%. Fujiyama Power Systems’s current P/E of 0.00x ...

Eli Lilly on Monday announced new price cuts for its popular weight loss drug Zepbound, broadening access for patients and driving greater use of the company’s digital healthcare platform, LillyDirect ...

Dec 1 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it has lowered the price of single-dose vials of its popular obesity drug Zepbound to make the treatment more affordable for U.S.

The latest eBay-created build is going to comedian Pete Davidson, and it may be a shock that it’s not a supercar or muscle ...

Eli Lilly & Co. is cutting the price for introductory doses of its weight-loss drug Zepbound again, as competition heats up with rival Novo Nordisk A/S. Starting Monday, the lowest dose vial will cost ...